Rheumatology International

, Volume 32, Issue 12, pp 4061–4063 | Cite as

Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment

  • P. G. Sanz
  • C. V. García MéndezEmail author
  • A. L. Cueto
  • V. B. Silva
  • J. C. Walther
  • R. A. Diez
  • S. Martins
  • R. J. Giannaula
Short Communication


A patient with chronic inflammatory demyelinating polyradiculoneuropathy and systemic lupus erythematosus arising after rubella vaccination was initially treated with plasmapheresis, corticosteroids and intravenous immunoglobulins, with partial response. After shift to rituximab, most clinical symptoms improved markedly, emphasizing the possible role of this monoclonal antibody in conventional therapy-resistant cases.


CIDP Systemic lupus erythematosous Rituximab Rubella vaccine Autoimmunity 



CVGM is recipient of the Legado Peruilh Fellowship of the School of Medicine (University of Buenos Aires). Only institutional funds of either the Hospital Español or the University of Buenos Aires were used. During the course of this study, CVGM was supported by a Legado Peruilh Fellowship of the School of Medicine (University of Buenos Aires), under the direction of Dr Diez.

Conflict of interest

The authors declare that they have no conflict of interest. All authors participated in the study according to their work duties (at either the Hospital Español or the University of Buenos Aires). In addition to the affiliation to the University, Dr Diez is part-time staff of a biotechnology company, unrelated to this study. Drs Silva, García Méndez, Sanz and Giannaula participated in clinical trials sponsored by pharmaceutical companies, unrelated to the present study.


  1. 1.
    Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) (1991) Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS task force. Neurology 41:617–618Google Scholar
  2. 2.
    Smith EL, Shmerling RH (1999) The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement. Lupus 8:586–595PubMedCrossRefGoogle Scholar
  3. 3.
    Medical Research Council (1981) Aids to examination of the peripheral nervous system. Memorandum no. 45. Her Majesty’s Stationary Office, LondonGoogle Scholar
  4. 4.
    Kuitwaard K, Bos-Eyssen ME, Blomkwist-Markens PH, van Doorn PA (2009) Recurrences, vaccinations and long-term symptoms in GBS and CIDP. J Peripher Nerv Syst 14:310–315PubMedCrossRefGoogle Scholar
  5. 5.
    Csurhes PA, Sullivan AA, Green K, Pender MP, McCombe PA (2005) T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 76:1431–1439Google Scholar
  6. 6.
    Sanvito L, Makowska A, Gregson N, Nemni R, Hughes RA (2009) Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy. Autoimmunity 42:667–677Google Scholar
  7. 7.
    Kim HJ, Jung CG, Jensen MA, Dukala D, Soliven B (2008) Targeting of myelin protein zero in a spontaneous autoimmune polyneuropathy. J Immunol 181:8753–8760PubMedGoogle Scholar
  8. 8.
    Inglis HR, Csurhes PA, McCombe PA (2007) Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy. J Neurol Neurosurg Psychiatry 78:419–422PubMedCrossRefGoogle Scholar
  9. 9.
    Stasi R (2010) Rituximab in autoimmune hematologic diseases: not just a matter of B cells. Semin Hematol 47:170–179PubMedCrossRefGoogle Scholar
  10. 10.
    Brannagan TH III (2009) Current treatments of chronic immune-mediated demyelinating polyneuropathies. Muscle Nerve 39:563–578PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • P. G. Sanz
    • 1
  • C. V. García Méndez
    • 1
    Email author
  • A. L. Cueto
    • 1
  • V. B. Silva
    • 1
  • J. C. Walther
    • 2
  • R. A. Diez
    • 3
  • S. Martins
    • 4
  • R. J. Giannaula
    • 1
  1. 1.Department of NeurologyHospital EspañolBuenos AiresArgentina
  2. 2.Department of NephrologyHospital EspañolBuenos AiresArgentina
  3. 3.Department of PharmacologySchool of Medicine, University of Buenos AiresBuenos AiresArgentina
  4. 4.Department of RheumatologyHospital EspañolBuenos AiresArgentina

Personalised recommendations